| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/06/2002 | EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177186A1 Ureas and their use as cell adhesion modulators |
| 02/06/2002 | EP1177185A1 4, 5, 6, 7-tetrahydroindazole derivatives as antitumor agents |
| 02/06/2002 | EP1177181A1 Substituted bicyclic compounds |
| 02/06/2002 | EP1177178A1 Heterocyclically substituted benzimidazoles, the production and application thereof |
| 02/06/2002 | EP1177177A1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands |
| 02/06/2002 | EP1177176A1 Tri-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177175A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 02/06/2002 | EP1177173A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors |
| 02/06/2002 | EP1177172A1 3a,4,5,9b-TETRAHYDRO-1H-BENZ e]INDOL-2-YL AMINE-DERIVED NEUROPEPTIDE Y RECEPTORS LIGANDS USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS |
| 02/06/2002 | EP1176963A2 Use of dopamine d 3? receptor ligands for producing medicaments for treating kidney disorders |
| 02/06/2002 | EP1176958A1 Novel catechols as antimicrobial agents |
| 02/06/2002 | EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/06/2002 | EP0892794B1 Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action |
| 02/06/2002 | EP0882024B1 Retroviral protease inhibiting compounds |
| 02/06/2002 | EP0734386B1 Platelet activating factor antagonists: imidazopyridine indoles |
| 02/06/2002 | CN1334812A Piperazine derivatives |
| 02/06/2002 | CN1334811A Tricyclic farnesyl protein transferase inhibitors |
| 02/06/2002 | CN1334810A Process for preparing tricyclic compound having antihistaminic activity |
| 02/06/2002 | CN1334806A Beta-amide and beta-sulfonamide carboxylic acid derivs., their preparation and their use as endothelin receptor antagonists |
| 02/06/2002 | CN1334801A Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 02/06/2002 | CN1078889C Non-pepitde tachykinin receptor antagonists |
| 02/05/2002 | US6344564 Fungicidal 2-imidazolin-5-ones and 2-imidazoline-5-thiones |
| 02/05/2002 | US6344468 Substituted isoindolones and their use as cyclic GMP modulators in medicaments |
| 02/05/2002 | US6344467 Antiasthmatic, antiallergic and immunosuppressant/immunomodulating properties |
| 02/05/2002 | US6344464 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination |
| 02/05/2002 | US6344463 Skin disorders, acne |
| 02/05/2002 | US6344462 Heterocyclic compounds as bradykinin antagonists |
| 02/05/2002 | US6344456 Piperazinone derivatives and their uses |
| 02/05/2002 | US6344453 Insecticidal heterocyclic compounds |
| 02/05/2002 | US6344450 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/05/2002 | US6344449 Headache and morphine dependence |
| 02/05/2002 | US6344358 Administering somatostatin releasing agent to treat brain, psychological and nervous system disorders such as schizophrenia, amnesia, bipolar disorder, alzheimer*s disease and parkinson*s disease |
| 02/05/2002 | CA2123403C Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| 01/31/2002 | WO2002008475A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 01/31/2002 | WO2002008232A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/31/2002 | WO2002008224A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 01/31/2002 | WO2002008223A1 Indole derivatives useful for the treatment of cns disorders |
| 01/31/2002 | WO2002008222A2 HETEROARYL-β-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS |
| 01/31/2002 | WO2002008221A2 Capsaicin receptor ligands |
| 01/31/2002 | WO2002008205A1 Substituted 5-alkynyl pyrimidines having neurotrophic activity |
| 01/31/2002 | WO2002008203A2 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by vla-4 |
| 01/31/2002 | WO2002008202A2 Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by vla-4 |
| 01/31/2002 | WO2002008201A2 Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by vla-4 |
| 01/31/2002 | WO2002008200A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 01/31/2002 | WO2002008195A1 Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesired microorganisms |
| 01/31/2002 | WO2002008193A2 Therapeutic acridone and acridine compounds |
| 01/31/2002 | WO2002008192A1 Novel heteroaryl derivatives and the use thereof as pharmaceuticals |
| 01/31/2002 | WO2002008185A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 01/31/2002 | WO2002008178A1 New combination of serotonin agonist (5ht2) and antagonist (5ht6)as pharmaceutical formulation |
| 01/31/2002 | WO2001070737A3 Therapeutic heterocyclic compounds for the treatment of asthma and allergy and use thereof |
| 01/31/2002 | WO2001040184B1 Methods for the syntheses of alfentanil, sufentanil and remifentanil |
| 01/31/2002 | US20020013468 Chemical intermediate for macrolactone antibiotic |
| 01/31/2002 | US20020013464 Reacting a benzamidine compound with a amide substituted pyrazole compound |
| 01/31/2002 | US20020013460 Condensed pyridine compound |
| 01/31/2002 | US20020013351 Compounds possessing neuronal activity |
| 01/31/2002 | US20020013349 Administering drug which opens potassium channel for reducing pain |
| 01/31/2002 | US20020013341 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, Bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition |
| 01/31/2002 | US20020013333 As inhibitors of matrix metalloproteinase, for therapy of diseases such as degenerative diseases and certain cancers |
| 01/31/2002 | US20020013326 For controlling harmful insects, acarina and nematodes |
| 01/31/2002 | US20020013322 Novel compounds for enhancing chemotherapy |
| 01/31/2002 | US20020013321 Used as ligands for opioid receptors, for therapy of neurological and gastrointestinal disorders |
| 01/31/2002 | US20020013310 Inhibitors of the activity of Factor Xa such as 3-((1-(4-Aminoquinolin-7-ylmethyl)-2-oxopyrrolidin-3-(R)-yl)-( 5- chloro-1H-indol-2-ylmethyl)amino)propionic acid methyl ester |
| 01/31/2002 | US20020012977 Enzymatic oxidations |
| 01/31/2002 | DE10035144A1 Cyclische Aminosäurederivate Cyclic amino acid derivatives |
| 01/31/2002 | DE10034801A1 Substituierte Amidoalkyl-uracile und ihre Verwendung Substituted amidoalkyl uracils and their use |
| 01/31/2002 | DE10032456A1 Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen Rapidly disintegrating dosage form for the delivery of drugs to the oral cavity or into body cavities |
| 01/31/2002 | CA2417192A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 01/31/2002 | CA2415740A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 01/31/2002 | CA2415606A1 Capsaicin receptor ligands |
| 01/31/2002 | CA2411192A1 Combination of serotonin agonist (5ht2) and antagonist (5ht6)as a pharmaceutical formulation |
| 01/31/2002 | CA2354236A1 Use of glycogen phosphorylase inhibitors to inhibit tumor growth |
| 01/30/2002 | EP1176144A1 N-triazolylmethyl-piperazine derivatives as neurokinine receptor-antagonists |
| 01/30/2002 | EP1176143A1 Anhydrous purification of nicotine using an ion exchange resin |
| 01/30/2002 | EP1176142A1 Process for the preparation of pyrazoles |
| 01/30/2002 | EP1176141A1 HETEROCYCLIC COMPOUNDS HAVING EFFECT OF ACTIVATING NICOTINIC ACETYLCHOLINE $g(a)4$g(b)2 RECEPTOR |
| 01/30/2002 | EP1176140A1 Amide compounds and medicinal use thereof |
| 01/30/2002 | EP1175417A1 Substituted benzolactam compounds |
| 01/30/2002 | EP1175416A1 Heteroaryl diazacycloalkanes, their preparation and use |
| 01/30/2002 | EP1175409A1 Pyrimidinones derivatives for the treatment of atherosclerosis |
| 01/30/2002 | EP1175408A1 Pyrimidinone compounds |
| 01/30/2002 | EP1175406A1 Imidazoline derivatives as alpha-1a adrenoceptor ligands |
| 01/30/2002 | EP1175402A1 Piperidine derivatives useful as ccr5 antagonists |
| 01/30/2002 | EP1175401A1 Piperazine derivatives useful as ccr5 antagonists |
| 01/30/2002 | EP1175400A1 Renin inhibitors |
| 01/30/2002 | EP1175399A1 Inhibitors of c-jun n-terminal kinases (jnk) |
| 01/30/2002 | EP1175398A1 Indoline derivatives as progesterone antagonists |
| 01/30/2002 | EP1175397A1 3,3-substituted indoline derivatives |
| 01/30/2002 | EP1175213A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/30/2002 | EP1019395B1 Farnesyl transferase inhibiting 2-quinolone derivatives |
| 01/30/2002 | EP0836602B1 Fungicidal pyrimidinones |
| 01/30/2002 | EP0707580B1 Magnesium omeprazole |
| 01/30/2002 | CN1333767A Aromatic heterocyclic compounds as antiinflammatory agent |
| 01/30/2002 | CN1333766A Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds as factor xainhibitors |
| 01/30/2002 | CN1333765A Cycloalkyl-substituted aminomethylpyrrolidine derivatives |
| 01/30/2002 | CN1333759A Acrylonitrile compounds |
| 01/30/2002 | CN1333758A Substituted bicyclic derivatives useful as anticancer agents |
| 01/30/2002 | CN1333757A Quinazoline derivatives as medicaments |
| 01/30/2002 | CN1333753A Quinolinecarboxamides as antiviral agents |
| 01/30/2002 | CN1333751A Substituted pyridine Herbicides |